EU Herbal Medicinals Marketing Authorization Model Proposed By AESGP
This article was originally published in The Tan Sheet
Executive Summary
A two-stage model for classifying herbal medicinal products for marketing authorization based on scientific profile is recommended by the Association of the European Self-Medication Industry in a report, "The Future of Medicine Regulation in Europe," released in January. AESGP is issuing the document as a precursor to a more formal debate on the European marketing authorization process slated for 2001.